{"transactions":[{"id":2802928,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T18:30:56.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":8168,"price":92.37,"value":754478.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are held of record by a living trust, for which the Reporting Person serves as Trustee."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $91.01 to $93.50."}],"balance_after":24427,"source":{"system":"sec-edgar","filing":"0001367644-21-000051","document":"wf-form4_161524624160313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000136764421000051/wf-form4_161524624160313.xml","form_type":"4"}},{"id":3052134,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T17:08:00.000Z","date":"2020-08-18","kind":"sale","acquired":false,"shares":4665,"price":128.3095,"value":598563.8175,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices between $128.25 and $128.47."}],"balance_after":32595,"source":{"system":"sec-edgar","filing":"0001367644-20-000139","document":"wf-form4_159787126712250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000136764420000139/wf-form4_159787126712250.xml","form_type":"4"}},{"id":3120176,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-05T16:33:47.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":5322,"price":87.503,"value":465690.966,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $86.64 to $88.65."}],"balance_after":37260,"source":{"system":"sec-edgar","filing":"0001367644-20-000100","document":"wf-form4_159138920953180.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000136764420000100/wf-form4_159138920953180.xml","form_type":"4"}},{"id":3134973,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T08:35:11.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":2821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":42582,"source":{"system":"sec-edgar","filing":"0001367644-20-000070","document":"wf-form4_159049649319393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000136764420000070/wf-form4_159049649319393.xml","form_type":"4"}},{"id":3237878,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T17:28:48.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":6572,"price":56.9282,"value":374132.1304,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average sale price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.49."}],"balance_after":39761,"source":{"system":"sec-edgar","filing":"0001367644-20-000023","document":"wf-form4_158318811165658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000136764420000023/wf-form4_158318811165658.xml","form_type":"4"}},{"id":3342232,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-13T09:21:37.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":8375,"price":53.46,"value":447727.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's stock incentive plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average sale price. These shares were sold in multiple transactions in prices ranging from $53.08 to $53.82."}],"balance_after":46333,"source":{"system":"sec-edgar","filing":"0001367644-19-000069","document":"wf-form4_157624687889376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000136764419000069/wf-form4_157624687889376.xml","form_type":"4"}},{"id":3510162,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T20:09:22.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":5736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":54708,"source":{"system":"sec-edgar","filing":"0001567619-19-012273","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761919012273/doc1.xml","form_type":"4"}},{"id":3748764,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":3158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":13.37,"expiration_date":"2019-05-16","underlying":"Common Stock","underlying_shares":3158},"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748763,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":4736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":13,"expiration_date":"2020-05-22","underlying":"Common Stock","underlying_shares":4736},"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748762,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":1579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":20.08,"expiration_date":"2021-05-18","underlying":"Common Stock","underlying_shares":1579},"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748761,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":8244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":18.64,"expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":8244},"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748760,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":3158,"price":69.6197,"value":219859.0126,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive."}],"balance_after":48972,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748759,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":3158,"price":13.37,"value":42222.46,"ownership":{"direct":true},"balance_after":52130,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748758,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":4736,"price":69.6197,"value":329718.8992,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive."}],"balance_after":48972,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748757,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":4736,"price":13,"value":61568.0,"ownership":{"direct":true},"balance_after":53708,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748756,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":1579,"price":69.6197,"value":109929.5063,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive."}],"balance_after":48972,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748755,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":1579,"price":20.08,"value":31706.32,"ownership":{"direct":true},"balance_after":50551,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748754,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":8244,"price":69.6197,"value":573944.8068,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive."}],"balance_after":48972,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3748753,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T16:41:25.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":8244,"price":18.64,"value":153668.16,"ownership":{"direct":true},"balance_after":57216,"source":{"system":"sec-edgar","filing":"0001567619-18-007116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000156761918007116/doc1.xml","form_type":"4"}},{"id":3918489,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T18:25:14.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":4895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the day prior to the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":48972,"source":{"system":"sec-edgar","filing":"0001140361-18-025558","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036118025558/doc1.xml","form_type":"4"}},{"id":4302863,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T13:46:02.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":44077,"source":{"system":"sec-edgar","filing":"0001140361-17-022469","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117022469/doc1.xml","form_type":"4"}},{"id":4486548,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":2061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Consists of an option granted under the company's stock incentive plan as amended and restated. The grant was made prior to the spin-off."},{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":8244,"derivative":{"exercise_price":18.64,"expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":2061},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486547,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":10305,"derivative":{"exercise_price":18.64,"expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486546,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":3157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Consists of an option granted under the company's stock incentive plan as amended and restated. The grant was made prior to the spin-off."},{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":4736,"derivative":{"exercise_price":13,"expiration_date":"2020-05-22","underlying":"Common Stock","underlying_shares":3157},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486545,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":7893,"derivative":{"exercise_price":13,"expiration_date":"2020-05-22","underlying":"Common Stock","underlying_shares":693},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486544,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":4735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Consists of an option granted under the company's stock incentive plan as amended and restated. The grant was made prior to the spin-off."},{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":3158,"derivative":{"exercise_price":13.37,"expiration_date":"2019-05-16","underlying":"Common Stock","underlying_shares":4735},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486543,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":7893,"derivative":{"exercise_price":13.37,"expiration_date":"2019-05-16","underlying":"Common Stock","underlying_shares":693},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486542,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":3157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Consists of an option granted under the company's stock incentive plan as amended and restated. The grant was made prior to the spin-off."},{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":1579,"derivative":{"exercise_price":20.08,"expiration_date":"2021-05-18","underlying":"Common Stock","underlying_shares":3157},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486541,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":4736,"derivative":{"exercise_price":20.08,"expiration_date":"2021-05-18","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486540,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":3157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Consists of an option granted under the company's stock incentive plan as amended and restated. The grant was made prior to the spin-off."},{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":14.71,"expiration_date":"2020-05-19","underlying":"Common Stock","underlying_shares":3157},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486539,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":3157,"derivative":{"exercise_price":14.71,"expiration_date":"2020-05-19","underlying":"Common Stock","underlying_shares":277},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486538,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":3157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Consists of an option granted under the company's stock incentive plan as amended and restated. The grant was made prior to the spin-off."},{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":10.64,"expiration_date":"2019-05-20","underlying":"Common Stock","underlying_shares":3157},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486537,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":3157,"derivative":{"exercise_price":10.64,"expiration_date":"2019-05-20","underlying":"Common Stock","underlying_shares":277},"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486536,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":2061,"price":29.7789,"value":61374.3129,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486535,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":2061,"price":18.64,"value":38417.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."}],"balance_after":37879,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486534,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":3157,"price":29.7789,"value":94011.9873,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.68, inclusive."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486533,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":3157,"price":13,"value":41041.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."}],"balance_after":38975,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486532,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":4735,"price":29.7789,"value":141003.0915,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.68, inclusive."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486531,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":4735,"price":13.37,"value":63306.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."}],"balance_after":40553,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486530,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":3157,"price":29.7789,"value":94011.9873,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.68, inclusive."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486529,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":3157,"price":20.08,"value":63392.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."}],"balance_after":38975,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486528,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":3157,"price":29.7789,"value":94011.9873,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.68, inclusive."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486527,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":3157,"price":14.71,"value":46439.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."}],"balance_after":38975,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486526,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":3157,"price":29.7789,"value":94011.9873,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.68, inclusive."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486525,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":3157,"price":10.64,"value":33590.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey."}],"balance_after":38975,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486524,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"In connection with the spin-off the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486523,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the spin-off on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017 and May 2018."}],"balance_after":35241,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}},{"id":4486522,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":141674,"kind":"person","name":"Bailey Sue","position":1,"cik":"0001403769","reported_name":"Bailey Sue","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:33:44.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017."}],"balance_after":34637,"source":{"system":"sec-edgar","filing":"0001140361-17-002344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403769/000114036117002344/doc1.xml","form_type":"4"}}]}